金河生物 - Financials

金河生物 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008
+Revenue	2.4B	2.2B	2.1B	2.1B	1.8B	1.8B	1.6B	1.5B	1.5B	1.2B	840.0M	741.0M	770.0M	721.0M	590.0M	459.0M	444.0M
Revenue Growth %	9.1%	2.4%	2.2%	14.5%	1.9%	9.4%	11.7%	-2.5%	19.7%	48.8%	13.4%	-3.8%	6.8%	22.2%	28.5%	3.4%	--
Total Revenue	2.4B	2.2B	2.1B	2.1B	1.8B	1.8B	1.6B	1.5B	1.5B	1.2B	840.0M	741.0M	770.0M	721.0M	590.0M	459.0M	444.0M
Cost Of Revenue	1.6B	1.5B	1.5B	1.4B	1.2B	1.1B	1.0B	899.0M	984.0M	885.0M	580.0M	479.0M	522.0M	479.0M	405.0M	340.0M	346.0M
+Gross Profit	795.0M	642.0M	614.0M	651.0M	630.0M	653.0M	616.0M	559.0M	512.0M	365.0M	260.0M	262.0M	248.0M	242.0M	185.0M	119.0M	98.0M
Gross Margin %	33.5%	29.5%	28.9%	31.3%	34.7%	36.6%	37.8%	38.3%	34.2%	29.2%	31.0%	35.4%	32.2%	33.6%	31.4%	25.9%	22.1%
Total Operating Cost	2.3B	2.1B	2.0B	2.0B	1.7B	1.6B	1.4B	1.3B	1.3B	1.1B	758.0M	635.0M	671.0M	633.0M	529.0M	427.0M	426.0M
Selling Expenses	138.0M	143.0M	131.0M	123.0M	113.0M	130.0M	132.0M	113.0M	96.9M	69.0M	54.8M	57.9M	46.9M	40.9M	35.9M	28.3M	19.7M
Admin Expenses	286.0M	246.0M	239.0M	229.0M	222.0M	204.0M	204.0M	180.0M	189.0M	146.0M	114.0M	85.9M	81.9M	85.5M	64.7M	42.8M	37.0M
Rd Expenses	94.0M	74.0M	82.3M	72.3M	66.4M	60.7M	40.5M	33.5M	--	--	--	--	--	--	--	--	--
Finance Expenses	66.9M	48.0M	7.2M	64.9M	84.9M	43.7M	25.5M	67.2M	-2.3M	17.9M	1.1M	3.1M	12.0M	19.1M	17.8M	14.4M	19.7M
+Operating Income	98.6M	105.0M	121.0M	140.0M	129.0M	176.0M	197.0M	148.0M	209.0M	121.0M	83.4M	107.0M	99.1M	87.3M	61.5M	31.7M	18.5M
Operating Margin %	4.2%	4.8%	5.7%	6.7%	7.1%	9.9%	12.1%	10.2%	14.0%	9.7%	9.9%	14.4%	12.9%	12.1%	10.4%	6.9%	4.2%
Non Operating Income	1.6M	119,200	96,300	4.6M	18.9M	44.6M	934,600	1.3M	12.2M	8.1M	11.1M	2.7M	9.7M	4.3M	4.6M	1.3M	860,500
Non Operating Expenses	2.3M	3.4M	2.5M	1.4M	7.5M	417,600	3.9M	1.5M	6.1M	497,100	272,100	1.3M	872,800	205,500	1.9M	872,500	1.2M
Investment Income	-1.3M	-1.5M	-3.9M	--	--	--	--	433,700	-3.6M	265,200	1.1M	295,900	--	--	1,726	--	--
Fair Value Change Income	45,500	-3,800	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Asset Disposal Income	194,400	-363,800	-252,400	1.6M	--	190,800	-2,600	--	--	--	--	--	--	--	--	--	--
Asset Impairment Loss	82.0M	24.6M	27.1M	21.1M	12.8M	28.4M	16.1M	16.6M	596,400	5.7M	4.0M	3.4M	3.0M	4.2M	1.8M	-1.0M	720,200
Other Income	30.0M	21.2M	18.9M	17.6M	16.9M	14.0M	17.7M	16.0M	--	--	--	--	--	--	--	--	--
Income Before Tax	97.8M	101.0M	119.0M	143.0M	141.0M	220.0M	195.0M	147.0M	215.0M	129.0M	94.2M	108.0M	108.0M	91.4M	64.2M	32.2M	18.1M
Income Tax	13.5M	7.1M	730,200	20.8M	1.7M	29.9M	30.1M	37.3M	41.1M	12.8M	14.1M	17.5M	18.3M	14.5M	11.0M	6.1M	3.3M
+Net Income	84.3M	94.4M	118.0M	122.0M	139.0M	190.0M	164.0M	110.0M	174.0M	116.0M	80.1M	90.6M	89.6M	76.9M	53.2M	26.0M	14.8M
Net Margin %	3.6%	4.3%	5.6%	5.9%	7.7%	10.7%	10.1%	7.5%	11.6%	9.3%	9.5%	12.2%	11.6%	10.7%	9.0%	5.7%	3.3%
Net Income Attributable	100.0M	86.5M	75.6M	94.0M	117.0M	185.0M	164.0M	108.0M	164.0M	105.0M	77.2M	90.4M	89.6M	77.4M	52.8M	27.0M	15.9M
Minority Interest	-15.9M	8.0M	42.5M	28.1M	21.9M	5.4M	774,600	1.6M	10.1M	11.1M	2.9M	199,500	-16,900	-477,000	460,300	-986,500	-1.1M
Eps Basic	0.13	0.11	0.10	0.14	0.18	0.29	0.26	0.17	0.26	0.19	0.35	0.42	0.96	0.95	0.65	0.33	0.19
Eps Diluted	0.13	0.11	0.10	0.14	0.18	0.29	0.26	0.17	0.26	0.19	0.35	0.42	0.96	0.95	0.65	0.33	0.19

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008
Cash And Equivalents	636.0M	608.0M	491.0M	518.0M	315.0M	362.0M	492.0M	345.0M	239.0M	225.0M	229.0M	275.0M	373.0M	87.8M	61.4M	77.4M	71.8M
Trading Financial Assets	553,100	507,700	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Accounts Receivable	499.0M	463.0M	409.0M	353.0M	301.0M	311.0M	300.0M	289.0M	193.0M	168.0M	149.0M	112.0M	154.0M	108.0M	82.5M	83.3M	61.4M
Notes Receivable	79.9M	72.7M	51.5M	74.0M	--	--	105.0M	59.6M	19.8M	14.4M	8.8M	2.9M	150,000	--	--	--	--
Notes And Accounts Receivable	579.0M	535.0M	461.0M	427.0M	301.0M	311.0M	406.0M	348.0M	213.0M	183.0M	158.0M	115.0M	154.0M	108.0M	82.5M	83.3M	61.4M
Prepayments	17.7M	12.9M	17.6M	21.5M	30.6M	30.8M	27.1M	36.3M	63.7M	63.2M	54.2M	51.9M	18.2M	12.2M	7.9M	27.7M	6.4M
Inventory	635.0M	671.0M	676.0M	577.0M	447.0M	430.0M	366.0M	337.0M	300.0M	310.0M	301.0M	125.0M	116.0M	107.0M	113.0M	109.0M	101.0M
Total Current Assets	2.0B	2.0B	1.7B	1.6B	1.2B	1.2B	1.3B	1.1B	865.0M	802.0M	765.0M	575.0M	670.0M	325.0M	273.0M	305.0M	250.0M
Long Term Equity Investment	259,600	255,800	251,500	230,200	235,600	251,900	2.1M	1.4M	776,000	225.0M	221,000	220,200	227,000	227,500	166,200	--	--
Fixed Assets	--	1.4B	1.3B	913.0M	922.0M	876.0M	806.0M	719.0M	671.0M	526.0M	479.0M	309.0M	300.0M	308.0M	316.0M	296.0M	295.0M
Fixed Assets Total	2.0B	1.4B	1.3B	913.0M	922.0M	876.0M	806.0M	719.0M	671.0M	526.0M	479.0M	309.0M	300.0M	308.0M	316.0M	296.0M	295.0M
Construction In Progress	--	644.0M	301.0M	290.0M	123.0M	97.0M	68.9M	48.0M	11.5M	39.4M	9.7M	99.5M	1.8M	4.7M	3.9M	4.7M	7.7M
Construction In Progress Total	246.0M	646.0M	301.0M	290.0M	123.0M	97.1M	69.0M	48.1M	11.8M	39.7M	10.0M	101.0M	1.8M	4.7M	3.9M	4.7M	7.7M
Intangible Assets	640.0M	656.0M	630.0M	645.0M	626.0M	674.0M	677.0M	642.0M	671.0M	277.0M	251.0M	30.2M	28.8M	29.5M	29.6M	11.1M	11.3M
Long Term Deferred Expenses	16.8M	15.1M	7.3M	6.2M	11.6M	7.9M	4.3M	3.9M	2.5M	1.4M	18,100	72,400	60,000	120,000	--	180,000	240,000
Total Non Current Assets	3.6B	3.4B	2.8B	2.4B	2.1B	2.1B	2.0B	1.9B	1.8B	1.1B	754.0M	442.0M	333.0M	346.0M	351.0M	314.0M	317.0M
Total Assets	5.7B	5.5B	4.5B	4.1B	3.4B	3.3B	3.3B	3.0B	2.7B	1.9B	1.5B	1.0B	1.0B	671.0M	624.0M	619.0M	566.0M
Short Term Borrowings	1.0B	1.7B	1.2B	834.0M	1.1B	882.0M	884.0M	598.0M	296.0M	489.0M	50.0M	30.0M	60.0M	206.0M	230.0M	284.0M	256.0M
Accounts Payable	289.0M	250.0M	263.0M	122.0M	97.0M	152.0M	120.0M	130.0M	142.0M	113.0M	108.0M	52.7M	51.3M	33.8M	59.0M	40.5M	32.9M
Advance Receipts	49,300	23,100	400.00	400.00	711,400	19.9M	4.1M	7.7M	10.9M	5.0M	673,100	588,400	394,800	10.3M	1.2M	2.8M	2.4M
Contract Liabilities	17.9M	17.8M	25.7M	30.6M	23.8M	--	--	--	--	--	--	--	--	--	--	--	--
Total Current Liabilities	1.9B	2.3B	1.7B	1.2B	1.4B	1.1B	1.1B	855.0M	529.0M	812.0M	226.0M	100.0M	122.0M	315.0M	306.0M	407.0M	372.0M
Long Term Borrowings	966.0M	497.0M	296.0M	87.0M	135.0M	267.0M	265.0M	264.0M	206.0M	--	318.0M	--	--	--	50.0M	--	--
Total Non Current Liabilities	1.3B	680.0M	419.0M	204.0M	254.0M	392.0M	453.0M	467.0M	549.0M	18.7M	336.0M	16.7M	17.5M	21.3M	62.7M	15.9M	16.7M
Total Liabilities	3.2B	2.9B	2.1B	1.4B	1.6B	1.5B	1.6B	1.3B	1.1B	831.0M	563.0M	117.0M	140.0M	336.0M	369.0M	423.0M	389.0M
Paid In Capital	772.0M	780.0M	780.0M	780.0M	635.0M	635.0M	635.0M	635.0M	635.0M	218.0M	218.0M	109.0M	109.0M	81.7M	81.7M	81.7M	81.7M
Capital Reserve	880.0M	896.0M	889.0M	1.1B	422.0M	422.0M	445.0M	445.0M	424.0M	498.0M	498.0M	498.0M	498.0M	72.7M	69.7M	64.9M	64.9M
Surplus Reserve	139.0M	131.0M	123.0M	123.0M	120.0M	116.0M	94.6M	76.4M	63.6M	49.5M	44.2M	37.9M	28.3M	18.8M	10.6M	5.1M	2.0M
Retained Earnings	577.0M	560.0M	556.0M	481.0M	453.0M	499.0M	494.0M	368.0M	368.0M	268.0M	191.0M	256.0M	230.0M	150.0M	80.4M	33.1M	17.4M
Minority Equity	253.0M	270.0M	204.0M	258.0M	135.0M	128.0M	101.0M	111.0M	87.7M	19.4M	5.5M	-509,200	-857,300	11.9M	12.5M	11.2M	11.8M
Equity Attributable	2.2B	2.2B	2.2B	2.4B	1.6B	1.7B	1.7B	1.5B	1.5B	1.0B	951.0M	901.0M	864.0M	322.0M	242.0M	185.0M	166.0M
Total Equity	2.5B	2.5B	2.4B	2.7B	1.8B	1.8B	1.8B	1.6B	1.6B	1.1B	956.0M	900.0M	864.0M	334.0M	255.0M	196.0M	178.0M

Line Item	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021	FY 2020Dec 31, 2020	FY 2019Dec 31, 2019	FY 2018Dec 31, 2018	FY 2017Dec 31, 2017	FY 2016Dec 31, 2016	FY 2015Dec 31, 2015	FY 2014Dec 31, 2014	FY 2013Dec 31, 2013	FY 2012Dec 31, 2012	FY 2011Dec 31, 2011	FY 2010Dec 31, 2010	FY 2009Dec 31, 2009	FY 2008Dec 31, 2008
Cash From Sales	2.3B	2.1B	2.1B	2.0B	1.7B	1.8B	1.5B	1.4B	1.6B	1.3B	796.0M	801.0M	748.0M	729.0M	616.0M	480.0M	475.0M
Tax Refunds Received	75.1M	55.9M	56.2M	40.7M	36.9M	29.9M	6.0M	15.2M	22.8M	24.9M	30.9M	22.2M	17.7M	16.9M	10.2M	4.8M	12.6M
Total Operating Cash Inflow	2.5B	2.2B	2.2B	2.1B	1.8B	1.9B	1.6B	1.5B	1.7B	1.3B	852.0M	842.0M	782.0M	759.0M	633.0M	486.0M	505.0M
Cash Paid For Goods	1.4B	1.4B	1.6B	1.5B	1.0B	1.1B	978.0M	965.0M	968.0M	843.0M	667.0M	475.0M	498.0M	480.0M	375.0M	375.0M	396.0M
Cash Paid To Employees	363.0M	354.0M	303.0M	284.0M	253.0M	258.0M	261.0M	235.0M	174.0M	129.0M	118.0M	98.6M	86.8M	73.6M	60.4M	39.6M	45.2M
Taxes Paid	62.4M	49.6M	61.3M	53.9M	68.3M	79.6M	93.9M	90.7M	76.0M	43.7M	35.5M	44.0M	31.9M	34.0M	22.2M	16.6M	19.4M
Total Operating Cash Outflow	2.0B	2.0B	2.1B	2.0B	1.5B	1.6B	1.5B	1.5B	1.4B	1.1B	910.0M	693.0M	693.0M	652.0M	515.0M	462.0M	494.0M
Operating Cash Flow	498.0M	199.0M	124.0M	153.0M	258.0M	282.0M	117.0M	27.3M	292.0M	215.0M	-58.0M	148.0M	88.8M	107.0M	118.0M	23.2M	11.6M
Total Investing Cash Inflow	23.6M	231.0M	19.6M	5.4M	1,200	2.0M	1.4M	46.9M	41.8M	51.3M	131.0M	30.4M	--	--	1.1M	--	--
Total Investing Cash Outflow	395.0M	765.0M	406.0M	403.0M	204.0M	186.0M	193.0M	332.0M	498.0M	422.0M	479.0M	191.0M	51.5M	39.5M	56.0M	23.0M	27.5M
Investing Cash Flow	-371.0M	-534.0M	-387.0M	-398.0M	-204.0M	-184.0M	-192.0M	-285.0M	-456.0M	-371.0M	-347.0M	-160.0M	-51.5M	-39.5M	-54.9M	-23.0M	-27.5M
Cash From Borrowings	1.8B	2.0B	1.6B	1.2B	1.2B	903.0M	974.0M	793.0M	616.0M	489.0M	557.0M	190.0M	160.0M	283.0M	320.0M	362.0M	318.0M
Dividends And Interest Paid	161.0M	149.0M	60.1M	118.0M	234.0M	232.0M	75.0M	142.0M	98.8M	40.4M	31.9M	56.5M	14.6M	16.3M	15.7M	22.4M	16.3M
Debt Repayments	1.9B	1.4B	996.0M	1.6B	1.1B	901.0M	678.0M	433.0M	828.0M	302.0M	170.0M	220.0M	356.0M	307.0M	384.0M	334.0M	219.0M
Total Financing Cash Inflow	2.1B	2.1B	1.7B	2.2B	1.4B	973.0M	978.0M	829.0M	1.1B	574.0M	561.0M	190.0M	624.0M	283.0M	320.0M	362.0M	318.0M
Total Financing Cash Outflow	2.1B	1.7B	1.5B	1.7B	1.4B	1.2B	825.0M	575.0M	932.0M	378.0M	282.0M	276.0M	376.0M	324.0M	400.0M	357.0M	235.0M
Financing Cash Flow	-39.9M	413.0M	150.0M	449.0M	27.6M	-186.0M	154.0M	254.0M	207.0M	196.0M	279.0M	-86.4M	248.0M	-40.5M	-79.2M	5.5M	83.0M
Net Change In Cash	90.7M	86.7M	-90.3M	202.0M	74.1M	-86.3M	80.1M	-3.7M	45.0M	41.6M	-126.0M	-98.2M	286.0M	26.5M	-16.1M	5.6M	67.1M
Ending Cash Balance	588.0M	498.0M	411.0M	501.0M	300.0M	226.0M	312.0M	232.0M	235.0M	190.0M	149.0M	275.0M	373.0M	87.8M	61.4M	77.4M	71.8M
Capex	362.0M	457.0M	402.0M	384.0M	204.0M	179.0M	170.0M	197.0M	129.0M	142.0M	349.0M	161.0M	34.5M	39.4M	54.8M	23.0M	27.5M